false
0000896622
0000896622
2026-08-29
2026-08-29
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13
or 15(d) of the Securities Exchange Act of 1934
August 29, 2026
Date of Report (Date of earliest event reported)
AptarGroup,
Inc.
(Exact name of registrant as specified in its
charter)
Delaware
(State or other jurisdiction of
incorporation) |
|
1-11846
(Commission File Number) |
|
36-3853103
(IRS Employer Identification No.) |
265
Exchange Drive, Suite 301,
Crystal Lake, Illinois
60014
(Address of principal executive
offices)
Registrant’s
telephone number, including area code: 815-
477-0424
N/A
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
Trading
Symbol(s) |
Name of each exchange
on which registered |
| Common
Stock, $.01 par value |
ATR |
New
York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ¨
If an emerging growth
company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
| Item 5.02. |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On August 29, 2026, the Board of Directors (the “Board”)
of AptarGroup, Inc. (the “Company”) increased the size of the Board from ten (10) to eleven (11) directors and appointed
Gael Touya as a director, effective as of September 1, 2026. Mr. Touya will serve as a director for a term expiring at the Company’s
2028 annual meeting of stockholders and until his successor is duly elected and qualified. Mr. Touya is not expected to be appointed
to any committee of the Board.
As previously disclosed in the Company’s Current Report on Form 8-K
filed on March 17, 2026, Mr. Touya, who previously served as President of the Company’s Aptar Pharma segment, became President
and Chief Executive Officer of the Company effective September 1, 2026, succeeding Stephan B. Tanda, who retired from that position
on such date. Other than in connection with such chief executive officer succession, there are no arrangements or understandings between
Mr. Touya and any other persons pursuant to which Mr. Touya was appointed as a director of the Company. There are no family
relationships between Mr. Touya and any director or executive officer of the Company, and Mr. Touya has no direct or indirect
interest in any transaction, or proposed transaction, required to be disclosed pursuant to Item 404(a) of Regulation S-K.
As an employee of the Company, Mr. Touya does not receive any
additional compensation for his service as a director. The compensation arrangements relating to Mr. Touya’s service as President
and Chief Executive Officer were previously disclosed in the Company’s Current Report on Form 8-K filed on March 17, 2026.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
AptarGroup, Inc. |
| |
|
| Date: September 1, 2026 |
By: |
/s/ Irene Hudson |
| |
|
Irene Hudson |
| |
|
Executive Vice President, Chief Legal Officer and Secretary |